Answers are grounded in this paper and cite their sources.
Diabetic wounds are characterized by interacting pathological features, including oxidative stress, infection, inflammatory dysregulation, vascular insufficiency, proteolytic imbalance, and structural defects within heterogeneous wound beds. Injectable hydrogels offer a versatile platform that can conform to irregular defects, retain or deliver fragile therapeutics, and couple material behavior to local wound conditions. This Review evaluates these systems through a phenotype-to-platform framework that emphasizes minimum-sufficient design, mechanistic attribution, appropriate comparator selection, and translational considerations. Dynamic networks, stimuli-responsive gels, nanocomposites, and biologic depots have demonstrated substantial preclinical potential across a range of diabetic wound models. However, direct comparison across studies remains challenging because of differences in experimental models, outcome measures, control groups, treatment schedules, follow-up periods, and approaches to safety and manufacturing assessment. Collectively, the reviewed evidence suggests that progress may depend less on maximizing multifunctionality than on matching essential material functions to defined wound barriers and demonstrating durable repair using clinically informative comparators, reproducible formulations, and practical deployment strategies.
No takes yet. Share an insight, caveat, or question.
Hossein Omidian (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: